Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Closed
Phase 1
This trial is looking at a new vaccine made by altering people’s own donated leukaemia cells and injecting them back to trigger their immune system. You have the vaccine with the standard treatment of having white blood cells through a drip into a vein.
Recruitment start: 27 July 2009
Recruitment end: 9 August 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pramila Krishnamurthy
Experimental Cancer Medicine Centre (ECMC)
Guy's and St Thomas' NHS Foundation Trust
King's College London
Kings College Hospital NHS Foundation Trust
NIHR Biomedical Research Centres (BRCs) Award
Last reviewed: 21 Jun 2022
CRUK internal database number: 2578